Expression of KLK6 RNA is also linked to poor patient survival in a group of intracranial malignancies, including glioblastomas, meningiomas, oligodendrogliomas, ependymomas and other rare malignancies and brain metastases [12]. The gene discussed is KLK6; the disease is ependymoma.